Patients with BRAF mutation had significantly more right-sided and undifferentiated tumors, showed MSI status, had more infra and supradiaphragmatic adenopathy and peritoneal metastasis, and had less pulmonary disease, which is consistent with previous literature data. Here, BRAF is linked to lung disorder.